1Matz PG,Massa SM,Weinstein PR et al.Focal hyperexpression of hemeoxygenase-1 protein and messenger RNA in rat brain caused by cellular stress follwing subarachnoid injections of lysed blood[J].J N eurosurg,1996,85:892～900.
2Nakashima S,Tabuchi K,Shimokawa S et al.Combination therapy of fasudil hydrochloride and ozagrel sodium for cerebral vasospasm following aneurysmal subarachnoid hemorrhage [J].Neurol Med Chir (Tokyo),1998,38:805～811.
3Parsaee H,McEwan JR,Joseph S et al.Differential sensitivities of the prostacyclin and nitric oxide biosynthetic pathways to cytosolic calcium in bovine aortic endothelial cells[J].Br J Pharmacol,1992,107:1013～1019.
4Stoodly M,MacDonald RL,Weir B et al.Subarachnoid hemorrhage as a cause of an adaptive response in cerebral artenes [J].J Neurosurg,2000,93 (3):463-470.
5Aoki K,Williams R,Zhang JH.Mechanism of hemolysate-induced [Ca2 + ]i elevation in cultured fibroblasts [J].Neurol Res,2001,23 (4):367-373.
6Nishizawa S,Yamamoto S,Yokoyama T et al.Dysfunction of nitric oxide induces protein kinase C activation resulting in vasospasm after subarachnoid hemorrhage[J].Neurol Res,1997,19:558-562.
7Dietrich HH,Dacey RG.Molecular keys to the problems of cerebral vasospasm [J].Neurosurg,2000,46(3) :517-530.
8Takayasu M,Kajita Y,Suzuki Y et al.Oxyhemoglobin enhancement of vasopressin-induced constriction in rat cerebral arterioles [J].Life Scis,1995,56:PL123-PL127.
9Sobey CG.Cerebrovascular dysfunction after subarachnoid haemorrhage:novel mechanisms and directions for therapy[J].Clin Exp Pharmacol Physiol,2001,28 (11):926-929.
10Piepgras A .Thome C,Schmiedek P.Characterization of an anterior circulation rat subarachnoid hemorrhage model[J].Stroke,1995,26:2347-2352.
4HIRASHIMA Y,ENDO S,KATO R,et al.Prevevention of ceredrovasos pasm following subarach noid hemonhage in rabbits by the plateactivating factor antagonist,E5880[J].J Nearosurg,1996,84(5):826-830.
5VAUGHAN C J.Prevention of stroke and dementia with statins,effects beyond lipid lowering[J].Am J Eardiol,2003,91(4A):23-29.
